KERRAMAX CARE™ Gentle Border Super-Absorbent Dressing, PRD500-1177, 16 cm x 26 cm, 10 ea/bx
- 3M ID 7100238571
- UPC 05060077234239
Details
Highlights
- Super-absorbent dressings for absorbing and retaining high levels of exudate<sup>1*</sup>
- Sequesters and retains bacteria and MMPs<sup>2*,3*</sup> away from the wound bed, preventing the transmission risk of infection
- Gentle silicone adhesive border secures the dressing in position without the need for a secondary dressing or retention bandage
- Suitable for use under compression
- Can be left in place for several days
3M™ Kerramax Care™ Gentle Border Super-Absorbent Dressings are a range of super-absorbent dressings that absorb and retain high volumes of wound exudate1*. The unique wicking layer evenly distributes serous and viscous fluid both horizontally and vertically throughout the dressing, utilizing the full absorption capacity and helping to prevent bulking. Exudate is locked away, including bacteria2* and MMPs3* helping to create an optimal environment for wound healing. It is secured with an outer foam layer with a gentle silicone adhesive border.
3M™ Kerramax Care™ Gentle Border dressings offer an advanced method of absorbing exudate from wounds utilising Exu-Safe™ technology built into the dressings’ core. This super-absorbent core absorbs and retains moderate to high levels of fluid away from the wound bed protecting delicate wound tissue and surrounding skin whilst helping to reduce the risk of maceration, even under compression. A heat-sealed border prevents leakage whilst a soft, non-woven wound contact layer aids patient comfort.
1* Jackson, S. & Warde, D. Determination of free swell absorption and fluid retention, and absorption capacity under pressure of KERRAMAX CARE™. Crawford Healthcare Ltd. CHC R596. Knutsford, UK: 2017.
2* Singh, G. & Thomason, H. Sequestration and retention of bacteria by superabsorbent dressings over time. KCI. CHC R1043 (in vitro). University of Manchester & KCI Knutsford, UK. 2020.
3* Singh, G. & Thomason, H. Sequestration of matrix metalloproteinases (MMPs) by superabsorbent wound dressings. KCI. CHC R1042 (in vitro). University of Manchester & KCI Knutsford, UK. 2020.
* As demonstrated in vitro
Suggested applications
- Suitable for use with moderately to highly exuding pressure ulcers, leg ulcers and diabetic foot ulcers
Specifications
Resources
